Cannabidiol interactions in the voltage-gated calcium channel by molecular docking

Cannabidiol interactions in the voltage-gated calcium channel by molecular docking

Objective: to analyzer the interactions of cannabidiol in the CaV3.2 through molecular docking. Methodology: this is a research with in silico approach, which CBD and gabapentin (GBP) were employed as test substances, and CaV3.2 channel the target protein. Molecular docking experiments were realize...

Full description

Bibliographic Details
Main Authors:	Gisele Evelin de Jesus Arruda, Gidelson José Silva Júnior, Nathalia Napoli Mendes, Gustavo Napoli Mendes, Alessandra Emertice de Almeida Costa, Luana Carmélia de Lira Fernandes, Joelmir Lucena Veiga da Silva
Format:	Article
Language:	English
Published:	Faculdade de Medicina de Olinda 2023-06-01
Series:	Anais da Faculdade de Medicina de Olinda
Subjects:	Cannabidiol Drug analgesic Drug design Voltage-gated calcium channel
Online Access:	https://afmo.emnuvens.com.br/afmo/article/view/283

Similar Items

Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
by: Tereza Buchtova, et al.
Published: (2023-02-01)

Evaluation of the Analgesic Effect of High-Cannabidiol-Content Cannabis Extracts in Different Pain Models by Using Polymeric Micelles as Vehicles
by: Yoreny Román-Vargas, et al.
Published: (2023-05-01)

Development of Stimuli-Responsive Chitosan/ZnO NPs Transdermal Systems for Controlled Cannabidiol Delivery
by: Julia Radwan-Pragłowska, et al.
Published: (2021-01-01)

Consumer perception, knowledge, and uses of cannabidiol
by: Nguyen Cambrey PharmD, et al.
Published: (2023-10-01)

Cannabidiol interactions with voltage-gated sodium channels
by: Lily Goodyer Sait, et al.
Published: (2020-10-01)

Cannabidiol (CBD) as a Promising Anti-Cancer Drug
by: Emily S. Seltzer, et al.
Published: (2020-10-01)

Lipid-Drug Conjugates and Nanoparticles for the Cutaneous Delivery of Cannabidiol
by: Aleksandra Zielińska, et al.
Published: (2022-05-01)

Cannabidiol as Self-Assembly Inducer for Anticancer Drug-Based Nanoparticles
by: Eleonora Colombo, et al.
Published: (2022-12-01)

The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects
by: John S. Markowitz, et al.
Published: (2022-11-01)

Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters
by: José A. Crippa, et al.
Published: (2021-05-01)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
by: Umberto Raucci, et al.
Published: (2020-09-01)

Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
by: Patrycja Bielawiec, et al.
Published: (2020-03-01)

Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022)
by: José Diogo R. Souza, et al.
Published: (2022-11-01)

Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
by: Luisa Rocha, et al.
Published: (2020-03-01)

Nanocomposite Cryogel Carriers from 2-Hydroxyethyl Cellulose Network and Cannabidiol-Loaded Polymeric Micelles for Sustained Topical Delivery
by: Denitsa Momekova, et al.
Published: (2020-05-01)

Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles
by: Joanna Kuźmińska, et al.
Published: (2023-08-01)

Cannabidiol Treatment for Lennox-Gastaut Syndrome at a Single Tertiary Center in South Korea
by: Han Na Jang, et al.
Published: (2023-01-01)

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
by: Paul T. Kocis, et al.
Published: (2020-07-01)

Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis
by: Paweł Marzęda, et al.
Published: (2022-06-01)

Polysaccharide Cryogels Containing β-Cyclodextrin for the Delivery of Cannabidiol
by: Denitsa Momekova, et al.
Published: (2021-10-01)

Real‐world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study
by: Fabienne Kühne, et al.
Published: (2023-06-01)

Research progress in the management of vascular disease with cannabidiol: a review
by: Yilong Guo, et al.
Published: (2024-01-01)

Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence
by: Cecilia Zavala-Tecuapetla, et al.
Published: (2022-12-01)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
by: Gustavo Gonzalez-Cuevas, et al.
Published: (2021-10-01)

The effect of cannabidiol on seizure features and quality of life in drug-resistant frontal lobe epilepsy patients: a triple-blind controlled trial
by: Seyyed Reza Ebadi, et al.
Published: (2023-07-01)

Pharmacokinetics and tolerability of single-dose enteral cannabidiol and cannabidiolic acid rich hemp in horses (Equus caballus)
by: Alexander C. S. Thomson, et al.
Published: (2024-04-01)

Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs
by: Gabriel A. Garcia, et al.
Published: (2022-07-01)

The pharmacology and therapeutic role of cannabidiol in diabetes
by: Jin Zhang, et al.
Published: (2023-10-01)

Enhanced Skin Penetration of Cannabidiol Using Organosilane Particles as Transdermal Delivery Vehicles
by: Zahra Khabir, et al.
Published: (2023-02-01)

Evaluation of the efficacy of a cannabidiol and cannabidiolic acid rich hemp extract for pain in dogs following a tibial plateau leveling osteotomy
by: Sarah Klatzkow, et al.
Published: (2023-01-01)

Pharmacokinetics of cannabidiol-/cannabidiolic acid-rich hemp oil in juvenile cynomolgus macaques (Macaca fascicularis)
by: Tinika N. Johns, et al.
Published: (2023-11-01)

Cannabidiol Determination on Peripheral Capillary Blood Using a Microsampling Method and Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry with On-Line Sample Preparation
by: Federica Pigliasco, et al.
Published: (2020-08-01)

The Pro-neurogenic Effects of Cannabidiol and Its Potential Therapeutic Implications in Psychiatric Disorders
by: Miguel Á. Luján, et al.
Published: (2020-06-01)

Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges
by: Miguel Olivas-Aguirre, et al.
Published: (2022-03-01)

Epileptic Phenotype and Cannabidiol Efficacy in a Williams–Beuren Syndrome Patient With Atypical Deletion: A Case Report
by: Antonio G. Nicotera, et al.
Published: (2021-06-01)

Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations
by: José Diogo S. Souza, et al.
Published: (2022-05-01)

Formulation of Cannabidiol in Colloidal Lipid Carriers
by: Nadine Monika Francke, et al.
Published: (2021-03-01)

An In Silico Study for Expanding the Utility of Cannabidiol in Alzheimer’s Disease Therapeutic Development
by: Kyudam Choi, et al.
Published: (2023-11-01)

Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from <i>Cannabis sativa</i> (Henola Variety) Inflorescences
by: Anna Stasiłowicz-Krzemień, et al.
Published: (2023-09-01)

Hyponatremic Cognitive Dysfunction Resulting from Drug-Drug-Gene Interaction between Sertraline and Cannabidiol in an Intermediate CYP2C19 Metabolizer Patient
by: Jade Nanan, et al.
Published: (2022-09-01)